Science Explorer Back to mapMap
Discussion
Researcher · Prisma Health · United States

Ki Young Chung

Ki Young Chung publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Colorectal Cancer Treatments and Studies, Cancer Immunotherapy and Biomarkers and Cancer Treatment and Pharmacology.

ORCID 0000-0001-6586-2013 OpenAlex
World rank
#614,514
of 7,710,434 ranked researchers
Rank in United States
#210,362
of 1,627,098
Works
101
Citations
7.2k
Citations per work
71.7
h-index
26
i10-index 37Top 15% in Oncology
Ki Young Chung

What does Ki Young Chung research?

Ki Young Chung's work is mostly in Medicine (52%), Biochemistry, Genetics and Molecular Biology (11%), Immunology and Microbiology (5%).

Health Sciences: 53 works · 52.5% of their workMedicine: 53 works · 52.5% of their workOncology: 35 works · 35.1% of their workPulmonary and Respiratory Medicine: 9 works · 9.1% of their workSurgery: 8 works · 8.3% of their workEverything else: 32 works · 31.6% of their workLife Sciences: 16 works · 15.9% of their workBiochemistry, Genetics and Molecular Biology: 11 works · 11.0% of their workMolecular Biology: 6 works · 5.7% of their workCancer Research: 5 works · 5.3% of their workImmunology and Microbiology: 5 works · 4.9% of their workImmunology: 5 works · 4.9% of their workTHEIR WORKKi Young Chung101works
Life Sciences16%Health Sciences52%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine5352.5%
  2. Everything else3231.6%
    1. Biochemistry, Genetics and Molecular Biology1111.0%
    2. Immunology and Microbiology54.9%
  1. 1Oncology35% of their works
  2. 2Pulmonary and Respiratory Medicine9% of their works
  3. 3Surgery8% of their works
  4. 4Molecular Biology6% of their works
  5. 5Cancer Research5% of their works
  6. 6Immunology5% of their works

Research topics

Which keywords describe Ki Young Chung's research?

The keywords of their largest research topics: Chemotherapy, Cetuximab, KRAS Mutations, Tumor Microenvironment, Quality of Life, Immune Checkpoint Blockade, PD-1 and PD-L1 and Immunotherapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Chemotherapy494 topics
  2. Cetuximab261 topic
  3. KRAS Mutations261 topic
  4. Tumor Microenvironment232 topics
  5. Quality of Life212 topics
  6. Immune Checkpoint Blockade151 topic
  7. PD-1 and PD-L1151 topic
  8. Immunotherapy142 topics
  9. Chemotherapy-Induced Peripheral Neuropathy131 topic
  10. Taxanes131 topic
  11. Cancer Genomics91 topic
  12. Mutational Signatures91 topic
  13. Anal Cancer81 topic
  14. Chemoradiation81 topic
  15. Pancreatic Cancer81 topic
  16. Surgical Complications81 topic
  17. Endoscopic Resection71 topic
  18. Gastric Cancer71 topic
  19. CAR T Cells61 topic
  20. Chimeric Antigen Receptor61 topic

Where does Ki Young Chung work?

Ki Young Chung's main affiliation in the publication record is Prisma Health, United States.

How many publications and citations does Ki Young Chung have?

OpenAlex counts 101 works and 7,242 citations for Ki Young Chung, an h-index of 26, ranking #614,514 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Ki Young Chung

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Ki Young Chung. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.